Evaluation of the anticancer activity of CuDIPS in SJL/J mice. 1988

C G Crispens, and J R Sorenson
Department of Biology, University of Alabama, Birmingham, 35294.

A copper complex, Cu(II)2(3,5-diisopropylsalicylate)4 (CuDIPS) was found to have anticancer activity in the SJL/J tumor system. Toxic effects were eliminated by use of the subcutaneous rather than the intraperitoneal route of administration and, unlike Tween 80, polyvinyl alcohol was shown to have no effect on development of reticulum cell sarcoma when used as the carrier. Age at the onset of treatment was a factor of importance with significant reductions in tumor incidences when therapy was initiated at 20 or at 40 weeks, but not at 30 weeks of age. Maximal inhibitory effects on tumor incidence were achieved by CUDIPS concentrations of 0.35 mumol/mouse and 0.50 mumol/mouse. No difference in inhibitory influence was observed when mice were injected weekly rather than biweekly with the complex.

UI MeSH Term Description Entries
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

C G Crispens, and J R Sorenson
August 1969, National Cancer Institute monograph,
C G Crispens, and J R Sorenson
October 1980, Experientia,
C G Crispens, and J R Sorenson
April 1987, Clinical and experimental immunology,
C G Crispens, and J R Sorenson
November 1972, Cancer research,
C G Crispens, and J R Sorenson
January 1989, Anticancer research,
C G Crispens, and J R Sorenson
March 1979, Cellular immunology,
C G Crispens, and J R Sorenson
May 1975, Nature,
C G Crispens, and J R Sorenson
December 2001, Journal of the neurological sciences,
C G Crispens, and J R Sorenson
October 1967, Journal of the National Cancer Institute,
C G Crispens, and J R Sorenson
January 1976, Advances in experimental medicine and biology,
Copied contents to your clipboard!